Skip to main content
. 2023 Apr 13;14:1100617. doi: 10.3389/fphar.2023.1100617

TABLE 3.

Results of overall disproportionality analysis.

Vaccine type Cases EBGM05 ROR (95% CI)
mRNA 48 0.37 1.42 (0.51–3.94)
Virus vector 5 0.34 1.57 (0.42–5.85)
In total 53 0.37 1.43 (0.52–3.96)